Isomorphic Labs Closes $2.1 Billion Series B to Push AI-Designed Drugs Toward First Clinical Trials 3 months ago AnaIn DealsFunding RoundsPartnerships
Stoke-Biogen Dravet Drug Cuts Seizures by 91% in Long-Term Data as Phase 3 Enrolment Wraps 3 months ago AnaIn Clinical TrialsTop Stories
Biotech M&A Reaches $106 Billion in 2026 as Patent Cliff Pressure and Recovering Markets Drive Record Deal Pace 4 months ago AnaIn DealsFunding RoundsPartnerships
Neurona Therapeutics Advances Rezanecel Toward Phase 3 After 97% Median Seizure Reduction in Long-Term Epilepsy Data 4 months ago AnaIn Clinical TrialsTop Stories
GSK Bets $10.6 Billion on Lung Cancer as Nuvalent Acquisition Reshapes Oncology Pipeline 4 months ago AnaIn DealsFunding RoundsPartnershipsTop Stories
Australia Approves Amtagvi as First T Cell Immunotherapy for Advanced Melanoma, Targeting the World’s Highest-Burden Population 4 months ago AnaIn Biopharma HighlightsBreaking NewsClinical TrialsTop Stories
FDA Clears First PROTAC Therapy in Oncology: Vepdegestrant Approved for ESR1-Mutated Advanced Breast Cancer 4 months ago AnaIn Clinical TrialsResearch Updates
NewLimit Raises $435 Million Series C to Advance Epigenetic Reprogramming Platform Targeting Age-Related Disease 4 months ago AnaIn Clinical TrialsDealsInvestmentsPartnerships
FDA Grants Dual Approval to Trastuzumab Deruxtecan in Early-Stage HER2-Positive Breast Cancer, Extending ADC Dominance 4 months ago AnaIn Breaking NewsClinical TrialsTop Stories
Shionogi’s Ensitrelvir Becomes First Oral Antiviral Approved for Post-Exposure COVID-19 Prevention 4 months ago AnaIn Clinical TrialsPharma Industry UpdatesResearch Updates
Tortugas Neuroscience Launches with $106 Million to Advance Four Clinical-Stage CNS Programs Licensed from Eisai and Hansoh 4 months ago AnaIn DealsFunding RoundsResearch UpdatesTop Stories
BioMarin Reports Positive Phase 3 Data for VOXZOGO in Hypochondroplasia 4 months ago AnaIn Biopharma HighlightsBreaking NewsClinical TrialsTop Stories
FDA Approves VEPPANU (Vepdegestrant), First Oral PROTAC Therapy for ESR1-Mutated Breast Cancer 4 months ago AnaIn Biopharma HighlightsBreaking NewsResearch Updates
Alzheimer’s Drug Pipeline Reaches Record Scale in 2026 With 192 Active Trials 4 months ago AnaIn Breaking NewsResearch UpdatesTop Stories
Biotech M&A Reaches $106 Billion in 2026 as Pharma Giants Race to Fill Pipelines 4 months ago AnaIn Breaking NewsBreakthroughsTop StoriesVenture Capital
